Iloprost Waymade

Iloprost, the active ingredient in Iloprost Waymade, is a prostacyclin analog presented as an intravenous formulation for intravenous use. It is employed in the management of pulmonary arterial hypertension and in treating digital ulcers associated with systemic sclerosis.

GNH USA supplies Iloprost Waymade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed to health‑care institutions across Europe and other regions, ensuring quality and traceability throughout the supply chain.

Iloprost acts as a prostacyclin analog targeting the pulmonary vascular and microvascular pathways.

Pulmonary arterial hypertension: improves hemodynamics and exercise capacity in patients with elevated pulmonary arterial pressure. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces the occurrence of new ulcers.

Iloprost may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate headache occurring during or after infusion. - Flushing: transient warmth and redness of the skin. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring medical intervention. - Pulmonary edema: accumulation of fluid in the lungs. - Bleeding events: increased risk of hemorrhage, especially with anticoagulants.

When using Iloprost, consider the following precautions to ensure safe therapy.

Renal impairment: monitor renal function and adjust therapy as needed. Hepatic impairment: use with caution; liver dysfunction may alter drug metabolism. Pregnancy: safety not established; avoid unless benefit outweighs risk. Concomitant anticoagulants: increased bleeding risk; close monitoring required. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iloprost can interact with several medications; awareness of these interactions helps optimize patient safety.

Major Interactions (Avoid): - Potent vasodilators (e.g., nitroglycerin): may cause severe hypotension. - Anticoagulants (e.g., warfarin, heparin): may increase bleeding risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may diminish antiplatelet effect of Iloprost. - Epoprostenol: additive vasodilatory effect may require dose adjustment. - Calcium channel blockers: may enhance hypotensive response.